Acurx Pharmaceuticals Inc (NASDAQ:ACXP) has a beta value of -1.72 and has seen 0.15 million shares traded in the last trading session. The company, currently
Lantern Pharma Inc (NASDAQ:LTRN) has a beta value of 1.60 and has seen 76019.0 shares traded in the last trading session. The company, currently valued
Monte Rosa Therapeutics Inc (NASDAQ:GLUE) has a beta value of 1.46 and has seen 0.27 million shares traded in the last trading session. The company,
PainReform Ltd (NASDAQ:PRFX) has a beta value of 0.63 and has seen 65124.0 shares traded in the last trading session. The company, currently valued at
My Size Inc (NASDAQ:MYSZ) has a beta value of 0.21 and has seen 67514.0 shares traded in the last trading session. The company, currently valued
Opus Genetics Inc (NASDAQ:IRD) has a beta value of 0.27 and has seen 0.19 million shares traded in the last trading session. The company, currently
OptimizeRx Corp (NASDAQ:OPRX) has a beta value of 1.30 and has seen 0.19 million shares traded in the last trading session. The company, currently valued
NLS Pharmaceutics Ltd (NASDAQ:NLSP) has a beta value of -0.36 and has seen 0.19 million shares traded in the last trading session. The company, currently
Mineralys Therapeutics Inc (NASDAQ:MLYS) has a beta value of 1.44 and has seen 0.25 million shares traded in the last trading session. The company, currently
Rallybio Corp (NASDAQ:RLYB) has a beta value of -1.49 and has seen 53831.0 shares traded in the last trading session. The company, currently valued at
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
